OUTCROP SILVER ANNOUNCES CONDITIONAL APPROVAL TO GRADUATE TO TSX

Stock Information for Finch Therapeutics Group Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Finch Therapeutics Group Inc.

OUTCROP SILVER EXTENDS AGUILAR VEIN 450 METRES SOUTH AND IDENTIFIES POTENTIAL NEW HIGH-GRADE SHOOTS IN BLIND TARGETS
OUTCROP SILVER GRADUATES TO TSX
Outcrop Silver Announces Closing of $23 Million Public Offering, Including Full Exercise of the Over-Allotment Option, Led by Investment from Jupiter Asset Management and Eric Sprott
Outcrop Silver Announces $20 Million Public Offering
OUTCROP SILVER STRENGTHENS TREASURY WITH $4.1 MILLION FROM WARRANT EXERCISES
OUTCROP SILVER EXTENDS HIGH-GRADE AT GUADUAL: 2.35 M OF 3,092 G/T SILVER; THREE-RIG PROGRAM ADVANCING RESOURCE EXPANSION
OUTCROP SILVER CONTINUES TO EXTEND LOS MANGOS VEIN TO THE NORTH
OUTCROP SILVER STRENGTHENS EXECUTIVE TEAM AHEAD OF RESOURCE UPDATE

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.